4.2.3 Antimanic drugs |
Link to Suggested Monitoring Requirements of High Risk Drugs For prophylaxis and treatment of mania. Monitor levels with lithium. A shared care guideline is available for the use of |
lithium, click here to access it. |
|
Carbamazepine |
Carbamazepine is licensed for partial and secondary generalised tonic-clonic seizures, primary generalised tonic-clonic |
seizures; trigeminal neuralgia; prophylaxis of bipolar disorder unresponsive to lithium. |
|
AMBER Carbamazepine |
tablets 100mg, 200mg, 400mg |
tablets m/r 200mg, 400mg |
liquid 100mg/5ml |
|
AMBER SHARED CARE |
Lithium carbonate sustained release tablets 200mg, 400mg |
(Priadel®) - Always prescribe by brand name |
AMBER Valproic acid e/c tablets 250mg, 500mg (Depakote®) |
|
Lamotrigine |
Lamotrigine is licensed for use as a mood stabiliser in bipolar disease. |
AMBER Lamotrigine tablets 25mg, 50mg |
|
|
|
Back to Main Chapter |
|
|
|
|
|
|
|
|
|
All material in this section is aimed at health care professionals, but is information currently held in the public domain, members of the |
public seeking advice on medicine-related matters are advised to speak with their GP, pharmacist, nurse or contact NHS111 Service |
Email: info.elmmb@nhs.net |
Copyright© 2016 East Lancashire Medicines Management Board. |
All rights reserved. Disclaimer/Terms and conditions |
|
|